Skip to main content
. 2014 Oct 21;20(39):14142–14155. doi: 10.3748/wjg.v20.i39.14142

Table 1.

Three protocols for prevention of recurrent hepatitis B virus infection after liver transplantation

HBIG-indefinite (HBIG continued for life) HBIG 10000 IU iv during anhepatic phase;
then 5000 IU iv daily for 5 d; followed by 800 IU im monthly indefinitely
Plus
ETV or TFV indefinitely
HBIG-light (HBIG for first 6 mo only) HBIG 10000 IU iv during anhepatic phase;
then 5000 IU iv daily for 5 d; followed by 800 IU im monthly for 6 mo
Plus
ETV and/or TFV indefinitely
HBIG-free (No HBIG) ETV and/or TFV indefinitely

ETV: Entecavir; HBIG: Hepatitis B immune globulin; im: Intramuscular; iv: Intravenous; TFV: Tenofovir. The appropriate annual costs of these are set out in Table 2.